Endocare Horizon urology stent clinicals to be under way in first half of 1998, CEO tells investors.
This article was originally published in The Gray Sheet
Executive SummaryENDOCARE UROLOGY STENT CLINICALS ON HORIZON FOR FIRST HALF OF 1998, Paul Mikus, chairman and CEO, stated at an Oct. 29 session of the Oppenheimer & Co. health care conference in New York City. The Horizon stent studies will evaluate the device in preventing urine retention caused by swelling after thermal treatment of benign prostatic hyperplasia.
You may also be interested in...
All medtech in Brazil will soon be subject to standardized industrial tariffs and development-related fiscal incentives, following a reform of rules relating to ICT across all industries.